一种合成在小鼠中具有形成不耐受性的抗过敏和抗抑郁作用
Yongjiang Wu1, Xiaofei Song2, YanZhe Ji1
1Center for Basic Medical Research, Medical School of Nantong University, Co-innovation Center of Neuroregeneration, Nantong, Jiangsu Province, China.
概括
一种新有效地减少了小鼠的疼痛和抑郁症,副作用最小. 这种,向阿片类受体 (ORs),显示出治疗慢性疼痛和并发性抑郁症的希望.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 疼痛管理 疼痛管理
背景情况:
- 慢性疼痛影响全球数以百万计的人,目前的治疗方法有效性有限,但具有显著的副作用,如耐受性和成.
- 迫切需要新型止痛药来管理慢性疼痛并改善患者的服从性.
- 针对阿片类受体 (ORs) 的多受体连接体显示出增强止痛和减少不良影响的潜力.
研究的目的:
- 为了研究一种新开发的 (VYWEMEDKN) 的止痛和抗抑郁作用.
- 评估的安全性,特别关注与阿片类药物相关的副作用.
- 探索在治疗慢性疼痛和抑郁症并发症方面的潜力.
主要方法:
- 在纳米分子度下进行内注射的 (VYWEMEDKN).
- 对原始小鼠疼痛敏感性的评估.
- 在痛感疼痛模型小鼠中评估与疼痛相关的行为.
- 使用强迫游泳试验和尾部悬浮试验评估抗抑郁药物的作用.
主要成果:
- 该显著降低了原始小鼠的疼痛敏感性.
- 在痛感性疼痛模型小鼠中观察到与疼痛相关行为的有效减少.
- 该在行为测试中显示出快速起作用的抗抑郁药效应.
- 在治疗中,观察到最少的阿片类药物相关副作用.
结论:
- 这种 (VYWEMEDKN) 具有强大的抗和抗抑郁药物特性.
- 观察到的效应可能通过阿片类受体 (OR) 途径进行介导.
- 这种代表了药物开发的有希望的候选人,用于治疗慢性疼痛和抑郁症并发症,并改善了副作用的概况.
相关概念视频
01:25Analgesia and Pain Management
582
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
582
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
279
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
279